Date | Insider | Price | Amount |
---|---|---|---|
1-30-2024 Insider Buy |
Geoffrey M. Parker CHIEF FINANCIAL OFFICER |
$3.59 CAGR » |
$683.05 190 shares |
1-12-2022 Insider Buy |
Joshua A. Kazam |
$12.60 CAGR » |
$189,000.00 15,000 shares |
10-15-2018 Insider Buy |
Arie Belldegrun Director |
$18.00 CAGR » |
$3,500,010.00 194,445 shares |
10-15-2018 Insider Buy |
Inc Pfizer >10% Owner |
$18.00 CAGR » |
$1,000,008.00 55,556 shares |
10-15-2018 Insider Buy |
Franz B. Humer Director |
$18.00 CAGR » |
$540,000.00 30,000 shares |
10-15-2018 Insider Buy |
Owen N. Witte Director |
$18.00 CAGR » |
$270,000.00 15,000 shares |
10-15-2018 Insider Buy |
TPG Group Holdings (SBS) Advisors, Inc. >10% Owner |
$18.00 CAGR » |
$12,150,000.00 675,000 shares |
Also See: Institutional Holders of ALLO
Also See: SEC filings
Growth of $10,000.00 Without Dividends Reinvested |
||
Start date: | 01/31/2024 | |
End date: | 05/02/2024 | |
Start price/share: | $3.52 | |
End price/share: | $2.97 | |
Dividends collected/share: | $0.00 | |
Total return: | -15.63% | |
Annualized Gain: | -62.67% | |
Starting investment: | $10,000.00 | |
Ending investment: | $8,437.00 | |
Years: | 0.25 |
Allogene Therapeutics Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.), and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these categories, but instead file their holdings quarterly on the latest form 13F filings. While recent Allogene Therapeutics insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding ALLO
Free ALLO Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |
Other companies seeing insider buying close in time to when the Allogene Therapeutics Insider Buying occurred are:
FinWise Bancorp Insider Buying |